CROI 2025 BHIVA working group summary

Caroline A Sabin¹, Tristan J Barber^{1

2}, Laura Waters^{1

3}, Nicola Mackie⁴, Clare van Halsema⁵, Anna Maria Geretti^{6

7}, Iain Reeves⁸, Laura Byrne⁹, Yvonne Gilleece^{10

11}

Affiliations

¹ Institute for Global Health, University College London, London, UK.
² Department of HIV Medicine, Royal Free London NHS Foundation Trust, London, UK.
³ Department of Sexual Health & HIV, Central and Northwest London NHS Foundation Trust, London, UK.
⁴ Imperial College Healthcare NHS Trust, London, UK.
⁵ Specialist Regional Infectious Diseases Unit, Manchester University NHS Foundation Trust, Manchester, UK.
⁶ Department of Medicine of Systems, Infectious Diseases Unit, University of Rome Tor Vergata, Rome, Italy.
⁷ Department of HIV Medicine, Royal Free London NHS Trust (NorthMid), London, UK.
⁸ Homerton Healthcare NHS Trust, London, UK.
⁹ St. George's University Hospitals NHS Foundation Trust, London, UK.
¹⁰ Brighton & Sussex Medical School, Brighton, UK.
¹¹ University Hospitals Sussex NHS Foundation Trust, Brighton, UK.

Editorial

Caroline A Sabin et al. HIV Med. 2025 Oct.

. 2025 Oct;26(10):1476-1484.

doi: 10.1111/hiv.70077. Epub 2025 Jul 16.

Caroline A Sabin¹, Tristan J Barber^{1

2}, Laura Waters^{1

3}, Nicola Mackie⁴, Clare van Halsema⁵, Anna Maria Geretti^{6

7}, Iain Reeves⁸, Laura Byrne⁹, Yvonne Gilleece^{10

11}

¹ Institute for Global Health, University College London, London, UK.
² Department of HIV Medicine, Royal Free London NHS Foundation Trust, London, UK.
³ Department of Sexual Health & HIV, Central and Northwest London NHS Foundation Trust, London, UK.
⁴ Imperial College Healthcare NHS Trust, London, UK.
⁵ Specialist Regional Infectious Diseases Unit, Manchester University NHS Foundation Trust, Manchester, UK.
⁶ Department of Medicine of Systems, Infectious Diseases Unit, University of Rome Tor Vergata, Rome, Italy.
⁷ Department of HIV Medicine, Royal Free London NHS Trust (NorthMid), London, UK.
⁸ Homerton Healthcare NHS Trust, London, UK.
⁹ St. George's University Hospitals NHS Foundation Trust, London, UK.
¹⁰ Brighton & Sussex Medical School, Brighton, UK.
¹¹ University Hospitals Sussex NHS Foundation Trust, Brighton, UK.

No abstract available

References

1. Kiweewa FM, Ahmed K, Nair G, et al. Adherence to F/TAF in cisgender women prevents HIV with low risk of resistance or diagnostic delay. 2025. CROI. Abstract 194.
1. Coutinho C, Hoagland B, Grinsztejn B, et al. ImPrEP CAB brasil: enhancing PrEP coverage with CAB‐LA in young key populations. CROI. Abstract 192. 2025.
1. Molina J‐M, Capitant C, Spire B, et al. On‐demand preexposure prophylaxis in men at high risk for HIV‐1 infection. N Engl J Med. 2015;373:2237‐2246.
1. Dumond JB, Sykes C, Schauer A, et al. Optimizing on‐demand tenofovir disoproxil fumarate/emtricitabine dosing in women for HIV prevention. 2025. CROI. Abstract 157.
1. Davey DLJ, Bheemraj K, Mvududu R. Impact of urine TFV testing on PrEP adherence in south African pregnant and postpartum women: an RCT. 2025. CROI. Abstract 166.